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Abstract  
 
Acromegalic patients present with volume expansion and arterial hypertension but the renal sites and 
molecular mechanisms of direct antinatriuretic action of growth hormone (GH) remain unclear. Here, 
we show that acromegalic GC rats, which are chronically exposed to very high levels of GH, exhibited 
a decrease of furosemide-induced natriuresis and an increase of amiloride-stimulated natriuresis 
compared to controls. Enhanced Na+,K+-ATPase activity and altered proteolytic maturation of 
epithelial sodium channel (ENaC) subunits in the cortical collecting ducts (CCD) of GC rats provided 
additional evidence for an increased sodium reabsorption in the late distal nephron under chronic GH 
excess. In vitro experiments on KC3AC1 cells, a murine CCD cell model revealed the expression of 
functional GH receptors (GHR) and IGF-1 receptors coupled to activation of JAK2/STAT5, ERK and 
AKT signaling pathways. That GH directly controls sodium reabsorption in CCD cells is supported by 
i) stimulation of transepithelial sodium transport inhibited by GHR antagonist pegvisomant ii) 
induction of αENaC mRNA expression iii) identification of STAT5 binding to a response element 
located in the αENaC promoter, indicative of the transcriptional regulation of αENaC by GH. Our 
findings provide first evidence that GH, in concert with IGF-1, stimulates ENaC-mediated sodium 
transport in the late distal nephron, accounting for the pathogenesis of sodium retention in acromegaly.  
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Introduction  
 
Chronic hypersecretion of growth hormone 
(GH) and subsequent hypersecretion of 
insulin-like growth factor-1 (IGF-1) in 
acromegaly leads to major cardiovascular 
complications which constitute the main cause 
(60%) of mortality. Arterial hypertension that 
occurs in 30–40% of acromegalic patients is 
one of the most important prognostic factors of 
increased mortality (1). Plasma volume 
expansion and increased cardiac output have 
been well documented and seem to play major 
roles in the pathophysiology of high blood 
pressure (2). In addition, increased 
extracellular volume is constantly present and 
accounts for soft-tissue swelling and 
organomegaly consistent with the 
antinatriuretic effects of GH (3). In contrast, 
adult GH-deficient patients have a reduction in 
plasma and extracellular volume which can be 
normalized by GH substitution (4). However, 
the molecular mechanisms by which GH 
controls sodium and water homeostasis remain 
poorly understood.  
The initial concept of indirect effects of GH 
via activation of the renin angiotensin 
aldosterone system (RAAS) (5-8) or decrease 
of the plasma atrial natriuretic peptide 
concentration (9-11) is controversial. Rather, 
several studies concluded to direct stimulatory 
effects of GH/IGF-1 on renal sodium and 
water reabsorption (7, 8, 10). Central questions 
remain whether GH controls tubular sodium 
transport directly or through its major target 
IGF-1, and in which segments of the nephron 
this potential antinatriuretic effect may occur.  
The presence of functional GH receptor (GHR) 
in target cells is a prerequisite for direct renal 
effects of GH. Indeed, in situ hybridization 
studies in the rat kidney showed that GHR 
mRNA expression was confined to the 
proximal tubule and the thick ascending limb 
of Henle’s loop (12). However, the expression 
of GHR in the distal nephron remains 
controversial (12-14). Recent observations 
have extended GHR expression to glomerular 
mesangial cells (15) and podocytes (16). In 
vitro microperfusion of rabbit proximal tubules 
exposed to GH and IGF-1 (17) as well as 
lithium clearance measurements, an important 
index of proximal tubular sodium reabsorption, 
in GH-treated patients (10) and rats (18), have 
excluded a prominent role of the proximal 
tubule in GH-induced sodium transport. 
Likewise, although a recent study reported that 
acute GH administration in rats results in 
increased phosphorylation of Na+,K+,2Cl- 
cotransporter (NKCC2) in the thick ascending 
limb (TAL) of the Henle’s loop, the lack of a 
concomitant GH-induced change in sodium 
transport questions the physiological relevance 
of this observation (18). Based on human 
metabolic studies, it has been alternatively 
suggested that GH may exert its effects in the 
distal nephron (8, 10) which plays a pivotal 
role in sodium homeostasis and constitutes the 
major segment mediating sodium-retaining 
effects of the mineralocorticoid hormone 
aldosterone (19). The classical view of 
aldosterone action is that it binds to the 
mineralocorticoid receptor (MR), a ligand-
dependent transcription factor, to modulate 
gene expression, resulting in induction of 
proteins implicated into the transepithelial 
ionic transport (20). Aldosterone-regulated 
transepithelial sodium reabsorption in the 
distal nephron occurs via the amiloride-
sensitive epithelial sodium channel (ENaC) 
located at the apical membrane and the 
basolateral Na+,K+-ATPase of cortical 
collecting duct (CDD) cells. ENaC is 
composed of three subunits (α, β and γ) (21) 
constituting the rate-limiting step of apical Na+ 
entry. Even though the presence of GHR in the 
distal nephron has been demonstrated in some, 
but not all studies (12-14), it has thus far never 
been functionally characterized. 
To address the direct impact of GH on the 
control of sodium handling and to localize its 
target site of action, we employed 
complementary approaches on various 
experimental models which all provided 
converging evidence for direct antinatriuretic 
effects of GH in the late distal nephron. 
Metabolic cage studies in an animal model of 
acromegaly, the GC rats bearing somatotropic 
cell tumors (22) allowed us to examine the 
influence of chronic GH hypersecretion on 
sodium balance in vivo and to identify the 
aldosterone-sensitive distal nephron as a direct 
target of GH action. To decipher the 
mechanisms by which GH stimulated 
transepithelial sodium transport, we used a 
highly differentiated cortical collecting duct 
(CCD) cell line, the KC3AC1 cells (23). This 
cell-based system enabled us to demonstrate, 
for the first time, the presence of functional 
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GHR in a CCD-derived cell line and to 
characterize the molecular targets involved in 
the pathophysiology of extracellular volume 
expansion in acromegaly.  
 
Materials and Methods  
 
Hormones and drugs 
GH and pegvisomant were kindly provided by 
Serono (Boulogne, France) and Pfizer (Paris, 
France), respectively. IGF-1, U0126 and 
Ly294002 were from Euromedex 
(Mundolsheim, France), AG490 was from 
VWR (Strasbourg, France), protein A 
sepharose CL-4B was from GE Healthcare 
(Uppsala, Sweden), and all other reagents were 
from Sigma-Aldrich (St Louis, MI).  
 
Animal studies 
Animal housing and metabolic studies were 
performed according to the French legislation. 
GC rats were generated as previously 
described (22). Briefly, 12 x 106 GC cells were 
injected subcutaneously into the flank of 8-wk-
old female Wistar-Furth rats (Charles River, 
France). Animals were maintained on a regular 
12h-light-dark cycle, fed ad libitum, and 
weighed weekly for 12 weeks. Water intake, 
baseline 24 h urine volume, urinary creatinine 
and electrolyte concentrations determined on 
an automatic analyzer (Konelab 20i, Thermo, 
Cergy Pontoise, France) were obtained for two 
consecutive days after three days of animal 
adaptation to encaging. Furosemide (40 mg/kg) 
was injected ip and urine was collected during 
consecutive 3 h urinary sample collections. 
Amiloride was given in the drinking water 
(150 mg/L) for 24 h with concomitant 24 h 
urinary sample collection. Amiloride intake 
was not different in GC and wild type rats 
when normalized to body weight (9.8 mg/kg vs 
10.2 mg/kg in controls). Plasma GH 
concentrations were determined by EIA as 
previously described (24). IGF-1 and 
aldosterone concentrations were measured by 
RIA. Three days after metabolic challenges, 
animals were sacrificed after anesthesia and 
kidneys were collected for histology and 
Western blot analysis. 
 
Na+/K+-ATP-ase assay 
Na+/K+-ATP-ase activity was determined using 
pools of 4-6 permeabilized proximal 
convoluted tubules, cortical thick ascending 
limbs of Henle’s loop or cortical collecting 
ducts as described previously (25). Na+/K+-
ATPase activity was taken as the difference 
between mean total and ouabain-resistant 
ATPase activities, each determined in 
triplicate. Values are means ± SEM from 
several animals. 
 
Cell culture 
KC3AC1 cells (passages 10-20) were seeded 
on collagen I-coated Transwell filters (Costar 
Corp. Brumath, France) or Petri dishes and 
routinely cultured at 37°C in a humidified 
incubator gassed with 5% CO2 within an 
epithelial medium composed of 
DMEM/HAM’s F12 (1:1); 2 mM glutamine; 
50 nM dexamethasone; 50 nM sodium selenite; 
5 µg/ml transferrin; 5 µg/ml insulin; 10 ng/ml 
EGF; 2 nM T3; 100 U/ml penicillin, 100 µg/ml 
streptomycin; 20 mM HEPES, pH 7.4 and 5% 
dextran charcoal-treated serum (DCC). To 
study GH actions, epithelial medium was 
replaced by a minimum medium having the 
same composition as the epithelial medium 
with omission of DCC, dexamethasone and 
EGF. To study IGF-1 effects, insulin was 
omitted to the minimal medium. 
 
RT-PCR and quantitative real time PCR 
Total RNA was extracted from cells with 
TRIZOL reagent (InVitrogen, Cergy Pontoise, 
France) and RNA were processed for RT-PCR 
analysis. Gene expression was quantified by 
real time PCR, using an ABI 7300 (Applied 
Biosystems, Foster City, CA). Results 
represent the relative expression for a given 
sample calculated as the ratio (amol of specific 
gene/fmol of 18S). Murine RNAs were 
extracted from pools of 20-50 microdissected 
nephronic segments and quantitative real time 
PCR was performed using a cDNA quantity 
corresponding to 0.1 mm of nephron. Results 
are expressed as molecules/mm tubule length. 
Supplemental Table 1 indicates primer 
sequences of genes analyzed.  
 
Western blot analysis and immunoprecipitation 
assay 
Total protein extracts were prepared from wild 
type and GHR knock-out mouse kidney and 
liver or from KC3AC1 cells. When GH or 
IGF-1 treatment was tested, cells were 
deprived for 3 or 24 h in the appropriate 
minimal media as indicated above. Tissues or 
cells were washed twice with ice-cold PBS and 
lysed at 4°C with lysis buffer. Immunoblots 
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were incubated overnight with following 
dilutions of primary antibodies: anti-GHR AL-
47, 1:1,000 (kindly provided by Pr. SJ. Frank, 
Birmingham, AL); anti-IGF-1Ra N20: sc-712, 
1:1,000, (Santa Cruz Biotechnology Inc., Santa 
Cruz, CA); anti-phospho-p44/42 MAPK E10, 
1:2,000; anti-p44/42 MAPK E10, 1:1,000; 
anti-phospho-AKT, 1:1,000; anti-AKT, 
1:1,000, (all from Cell Signaling Technology 
Inc, Beverly, MA) and anti-α, β and γEnaC 
subunits antibodies, 1:1000 (kindly provided 
by Dr. M. van Bemmelen and Pr. L. Schild, 
Lausanne, Switzerland) followed by incubation 
with peroxidase-conjugated goat anti-rabbit 
antibody, dilution 1:15,000 or anti-mouse 
antibody, dilution 1:20,000, respectively  
(Vector, Burlingame, CA) and visualized by 
the ECL+ detection kit (GE Heathcare). When 
indicated, immunoprecipitation was performed 
by incubating 1 mg of total proteins with anti-
STAT5 C17 antibody (Santa Cruz) overnight 
at 4°C and the immunoprecipitates were 
collected using protein A sepharose CL-4B 
beads (GE Healthcare), reduced in Laemmli 
buffer and subjected to 7.5% acrylamide SDS-
PAGE and western blot as described above. 
Electrotransferred proteins were incubated 
with monoclonal anti-phospho-tyrosine 
antibody (1:5,000, clone 4G10, Upstate 
Biotechnology, Lake Placid, NY) followed by 
incubation with the secondary antibody. For 
loading normalization, membranes were 
incubated with anti-STAT5 or anti- α tubulin 
(1:10,000, DM1A, Sigma). Quantitative 
analysis of specific signals was performed 
using Quantity One software (Biorad).  
 
Immunocytochemistry 
Cells cultured on Lab-Tek (Nunc), were 
washed in PBS then fixed with 10% buffered 
formol in PBS (pH 7.3) for 10 min, washed 
three times in PBS before processing for 
immunocytochemistry. Cells cultured on filters 
were fixed in 10% buffered formol in PBS (pH 
7.3) for 60 min, dehydrated and embedded in 
paraffin blocks. Serial sections were 
deparaffinized and antigen retrieval was 
performed in a microwave oven in pH 6 citrate 
buffer for 15 min. After blocking with 2.5% 
normal horse serum, cells were incubated 
overnight with dilution of primary antibodies 
as follows: anti-GHR AL-47, 1:500; anti-IGF-
1Rα, 1:400; anti-phospho-STAT5 sc-11761, 
1:200 (Santa Cruz). After endogenous 
peroxidase quenching, immunodetection was 
performed using the ImmPress reagent kit 
(Vector). Irrelevant rabbit immunoglobulins 
were used as negative controls. 
 
Ionic transport measurements 
Cells seeded on collagen I-coated Transwell 
filters were cultured for 6 days in the epithelial 
medium which was replaced by the appropriate 
minimal medium 24 h before hormonal 
stimulation. The next day, 500 µl of the 
supernatant were recovered from the medium 
bathing the apical and basolateral surface of 
KC3AC1 cells. Ionic concentrations were 
measured.   
 
EMSA 
Differentiated KC3AC1 cells were starved for 
3 h in insulin-containing miminal medium  and  
exposed to GH stimulation. Nuclear protein 
extraction and gel mobility shift assays were 
performed as described (26). Purified 
oligonucleotides were annealed and labeled 
with [32P]-dCTP (GE Healthcare) using the 
Klenow fragment of DNA polymerase (Life 
Technologies, Inc., Paisley, UK) to a specific 
activity of approximately 108 cpm/µg of DNA. 
Oligonucleotide sequences were as follows: 
αENaC-forward: 5'-
GCTTCTCTTCTCGGAACCTCA-3'; αENaC-
reverse: 5'-
GAAGAGAAGAGCCTTGGAGTG-3'. 
Protein-DNA complexes were separated from 
free DNA by electrophoresis on nondenaturing 
4.5% polyacrylamide gel in 0.25X Tris-borate-
EDTA buffer at 200 V for 1 h. Gels were dried 
and exposed to x-ray film at -80°C. 
 
Statistical analysis 
Data were analyzed for statistical significance 
using the software Prism 4 (GraphPad 
Software, San Diego, CA). We performed 
either non parametric Mann Whitney test, 
Kruskal-Wallis multi-variance analysis 
followed by a post- test analysis of Dunn’s 
comparison test or non parametric Spearman 
correlation. Levels of statistical significance 
were fixed for P values < 0.05.  
 
Results  
 
GH enhances sodium transport in the late 
distal nephron in GC rats 
To address the impact of GH hypersecretion on 
renal electrolyte balance, and to precise the site 
of altered sodium handling along the nephron, 
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metabolic studies coupled to pharmacological 
tests were performed in GC rats, an animal 
model of acromegaly. After 12 weeks of 
subcutaneous GC cell implantation leading to 
chronic GH hypersecretion, GC rats presented 
with a significant increase in body weight 
(434.7 ± 16.4 g vs 207.0 ± 3.7 g for wild-type 
(WT) animals, P<0.001), consistent with the  
very high GH concentrations in GC rats as 
compared with control group (WT 10.0 ± 1.4 
ng/mL and GC 8217.0 ± 1088.2 ng/mL, 
P<0.01). As expected, this was also 
accompanied by a signifiant increase in IGF-1 
levels (WT 395 ± 38 ng/mL and GC 1707 ± 
146 ng/mL, P<0.001). Interestingly, we 
constantly observed a dramatic 3.5-fold renal 
hypertrophy leading to a 1.6-fold increase in 
kidney weight/body weight ratio in 
acromegalic animals, suggesting a specific 
impact of chronic GH hypersecretion on 
kidney remodeling (Fig. 1A and 1B). In 
addition, histological examination disclosed a 
major interstitial oedema associated with a 1.7-
fold increase in glomerular size (WT 89.9 ± 
3.2 vs GC 155.9 ± 3.5 µm, P<0.01). Despite 
this glomerular hypertrophy which paralleled 
the renal hypertrophy, we did not observe any 
modification in the diameter of the 
microdissected cortical collecting ducts of the 
acromegalic animals (Fig. 1D).  
As shown in Fig. 2A and B, basal Na+ and K+ 
excretion did not differ in wild type (WT) and 
GC rats. Administration of furosemide, an 
inhibitor of the Na+/K+/2Cl- cotransporter, led 
to lower natriuretic responses and lower 
urinary Na+/K+ ratio in GC compared to WT 
rats (Fig. 2A). Given that furosemide increased 
luminal Na+ delivery downstream of the 
Henle’s loop, this difference might be 
accounted for by enhanced sodium 
reabsorption in the distal parts of the nephron. 
This hypothesis was validated by showing that 
the natriuretic response to amiloride, a potent 
inhibitor of ENaC, was enhanced 1.5-fold in 
GC rats, and was associated with decreased 
kaliuresis (urinary Na+/K+ ratio increased 3.8-
fold vs WT) (Fig. 2B). We clearly 
demonstrated an enhanced capacity of the late 
distal nephron of GC rats to reabsorb Na+ and 
secrete K+, in spite of a significant reduction in 
plasma aldosterone concentrations in GC rat 
compared to controls (Fig 2.C). We next 
measured the Na+/K+-ATP-ase activity, the 
motor of sodium reabsorption along the 
nephron, in discrete nephron segments and 
showed that the Na+/K+-ATP-ase activity was 
specifically increased in the CCD of GC rats 
whereas it was not altered in the proximal 
tubule (PCT) and the Henle's loop (cTAL) 
(Fig. 2D). Taken together, these in vivo studies 
provide direct evidence that chronic GH/IGF-1 
excess enhances sodium transport in the late 
distal nephron in acromegaly, independently of 
the renin-angiotensin-aldosterone system. 
 
Chronic GH excess enhances ENaC 
maturation by proteolytic cleavage of α and 
γ subunits 
Since sodium reabsorption in the aldosterone-
sensitive distal nephron is mainly mediated by 
ENaC, we examined the renal expression of its 
three subunits by Western blot analysis in the 
GC and WT rats. Fig. 3A shows unchanged 
expression of the 95-kDa and 55-kDa forms of 
α subunit but a distinct electrophoretic pattern 
of lower molecular mass bands observed in GC 
rats. Indeed, the expression of the 36-kDa 
fragment was decreased in GC rats, associated 
with a shift of the 38- to a 40-kDa band 
(Fig.3A , arrowhead). The expression of the 
100-110 kDa forms of the β subunit of ENaC 
remained unchanged (Fig. 3B). Furthermore, 
the abundance of the 85-kDa and 75-kDa 
forms of the γ subunit was not altered. 
Strikingly, an intermediate ~80-kDa fragment 
clearly appeared in GC rats compared to 
controls (Fig. 3C; arrowhead). Altogether, 
these results demonstrate that enhanced 
sodium transport prevailing in the distal 
nephron of GC rats correlates with a 
significant modification of ENaC maturation 
involving distinct proteolytic processing of the 
α and γ subunits. 
 
GHR and IGF-1R are expressed in cortical 
collecting duct cells  
To establish whether GH exerts direct effects 
in the distal parts of the nephron, we first 
analyzed the expression profile of GHR (left 
panel) and IGF-1R (right panel) mRNA on 
microdissected murine nephronic segments by 
quantitative real-time PCR (Fig. 4A). Beside 
the well-described expression of GHR and 
IGF-1R mRNAs in the proximal tubule and 
Henle’s loop, we detected substantial amounts 
of GHR and IGF-1R in the distal nephron with 
an expression gradient from the cortex to the 
medulla. To further investigate the molecular 
mechanisms involved in the antinatriuretic 
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effects of GH and/or IGF-1 in the CCD, we 
used the KC3AC1 cells which maintain 
aldosterone responsiveness and functional 
mineralocorticoid receptor signaling (23). 
When cultured on collagen-coated Petri dishes, 
KC3AC1 cells develop at confluence 
numerous domes, a characteristic 
morphological feature of highly differentiated 
polarized epithelial cells (Fig. 4B). The relative 
abundance of GHR and IGF-1R mRNA in 
undifferentiated and fully differentiated dome-
forming cells was measured by quantitative 
real-time PCR  and compared to that 
determined in microdissected murine CCD. 
We showed that the levels of receptor 
transcripts increase as a function of the cell 
differentiation (Fig. 4C) and the relative GHR 
transcript abundance in KC3AC1 cells was 
comparable to that of endogenous GHR 
expressed in isolated cortical collecting ducts, 
estimated at approx 0.25 amol/µg RNA or 
10,000 molecules /µg of cellular proteins. 
Western blot analysis using anti-GHR AL47 
antibody revealed a specific band migrating at 
115 kDa in KC3AC1 whole-cell lysates, also 
present in murine kidney and liver protein 
extracts. In contrast, it was absent in GHR 
knock-out mouse organs in which only the 82 
kDa non-specific bands were detected, thus 
confirming the specificity of the higher 
molecular weight band (Fig. 4D). These results 
are consistent with the presence of the GHR 
protein in KC3AC1 cells. IGF-1R protein 
expression was also analyzed by Western blot. 
Fig. 4E reveals two specific bands migrating at 
130 kDa and 200 kDa in KC3AC1 cell lysates 
and in murine kidney, providing evidence for 
the presence of the α subunit of IGF-1R 
protein. GHR and IGF-1R protein expression 
in KC3AC1 cells was further analyzed by 
immunocytochemistry. Fig. 4F and 4G 
illustrate GHR and IGF-1R immunostainings 
in KC3AC1 grown on Petri dishes, as well as 
in a monolayer of KC3AC1 cells cultured on 
filters. The GHR and IGF-1R 
immunoreactivity was predominantly localized 
to the cell membrane and the adjacent 
cytoplasm and was enhanced in the dome 
areas. Finally, KC3AC1 cells did not express 
IGF-1 either in basal conditions or after GH 
stimulation (data not shown). Collectively, 
these results demonstrate conclusively that 
KC3AC1 cells express GHR and IGF-1R both 
at mRNA and protein level but not IGF-1 
enabling us to distinguish direct GH-induced 
effects from those mediated via IGF-1. 
 
GHR and IGF-1R signaling in KC3AC1 cells  
To assess the functional integrity of GHR in 
KC3AC1 cells, we examined the activation of 
the classical GHR-associated signaling 
pathways. GH treatment led to a rapid STAT5 
phosphorylation visible as early as 5 min and 
sustained until 60 min after hormonal 
stimulation (Fig. 5A). This dose-dependent 
effect was maximal at a GH concentration of 
1000 ng/ml and was strongly antagonized 
(70%) by the JAK2 inhibitor AG490 and 
partially inhibited (40%) by the GHR 
antagonist pegvisomant as determined by 
image density quantification (Fig. 5B). 
Immunocytochemistry with an antiphospho-
STAT5 antibody showed a transient nuclear 
translocation of phosphorylated STAT5 in 
KC3AC1 cells 30 min after GH stimulation 
(Fig. 5C). GH exposure also induced a rapid 
and transient ERK1/2 phosphorylation with the 
maximal response 2 min after stimulation (Fig. 
5D). This effect was completely inhibited by 
the GHR antagonist pegvisomant and the MEK 
inhibitor U0126 (Fig. 5E). The IGF-1R 
signaling in KC3AC1 cells was also examined 
by activation of its canonical signaling 
pathways. As shown by western blot analysis, 
IGF-1 treatment at a concentration of 10 nM 
resulted in rapid and transient ERK1/2 
phosphorylation with maximal response 2 min 
after hormonal stimulation (Fig. 5F) and 
prolonged AKT phosphorylation lasting 5–30 
min (Fig. 5G). Full inhibition of these effects 
by the respective kinase inhibitors U0126 and 
Ly294002 proved the specificity of the IGF-1R 
signaling. Taken together, these studies 
provide strong evidence for the functional 
integrity of the GHR and IGF-1R signaling in 
KC3AC1 cells, thus constituting a suitable 
cell-based system to study biological effects of 
GH and IGF-1 in the CCD.  
 
GH and IGF-1 stimulate ionic transports in 
KC3AC1 cells 
To investigate the potential impact of GH  and 
IGF-1 on ionic transport in CCD cells, we used 
KC3AC1 cells cultured on Transwell filters 
that exhibited a high transpithelial resistance 
(5.27 ± 0.17 KΩ/cm2) and an amiloride-
sensitive short-circuit current (Isc) 23.95 ± 
5.27 µA consistent with an ENaC-dependent 
sodium transport (23). Ion concentrations in 
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the apical and basolateral compartments were 
measured after GH exposure (100 ng/ml). 
Under basal conditions, KC3AC1 cells 
generated apical to basolateral Na+ and Cl- 
gradients (Na+ : 4.40 ± 0.61 and Cl- : 3.60 ± 
0.34 mmol/ml/24 h) indicating a Na+/Cl- 
reabsorption, accompanied by a K+ secretion 
with basolateral to apical gradient of 1.22 ± 
0.21 mmol/ml/24h. GH treatment (100 ng/ml) 
induced a 60% increase in Na+ reabsorption 
and comparable increase in Cl- reabsorption 
(Fig. 6A and C). The effects were completely 
inhibited by the GHR antagonist pegvisomant, 
establishing unambiguously the involvement of 
GH/GHR activation cascade. Of note, GH did 
not significantly influence potassium transport 
under these experimental conditions (Fig. 6B). 
On the other hand, IGF-1 (10 nM) induced a 
100 % increase in Na+ with a 50% increase in 
Cl- transepithelial gradient. Importantly, it was 
accompanied by a sharp 3.5-fold increase in K+ 
transepithelial gradient (Fig. 6D–F). These 
findings demonstrate that GH exerts direct 
stimulatory effects on Na+ and Cl- reabsorption 
in CCD-derived cells, while IGF-1 induces 
Na+/Cl- reabsorption with a marked K+ 
secretion.  
 
αENaC is a direct GH target gene in cortical 
collecting duct cells 
To decipher the molecular bases of the GH-
induced increase in Na+ reabsorption, gene 
expression analyses were performed by 
quantitative real-time PCR experiments on 
GH-treated KC3AC1 cells. We first 
demonstrated that GH induced a 2 to 3-fold 
increase in the expression of SOCS2 and CIS, 
two classical GH target genes (Fig. 7A, upper 
and middle panels). GH exposure also led to a 
significant 30% increase in αENAC but not 
βENAC and γENAC mRNA steady state 
levels, suggesting that αENAC is a novel renal 
target of GH (Fig. 7A, lower panel). Since GH 
treatment of KC3AC1 cells induced STAT5 
phosphorylation (see Fig. 5A-C), we analyzed 
the promoter sequence of SCNN1A and 
identified a perfectly conserved STAT5 
response element located -2097 bp upstream of 
the transcription initiation start site of the gene. 
As shown in Fig. 7B, electromobility shift 
assays with nuclear proteins extracted from 
untreated or GH-treated KC3AC1 cells 
demonstrated the presence of specific STAT5-
RE-protein complexes in GH-treated extracts, 
suggesting that GH regulates αENaC 
transcription via STAT5 activation. 
Collectively, our results clearly demonstrate 
that αENaC expression is directly stimulated 
by acute exposure to GH, a finding consistent 
with the enhanced capacity of CCD cells to 
reabsorb sodium accounting for 
hydroelectrolytic retention observed in 
acromegaly. Since IGF-1 also regulated 
transepithelial ionic transport in this cell 
model, we examined the putative 
transcriptional control of IGF-1 on candidate 
target gene expression. At variance with GH, 
αENAC mRNA expression was not affected 
whereas the expression of Sgk1 transcripts was 
rapidly and transiently stimulated as early as 
30 min after IGF-1 exposure (Fig. 7C). Sgk1 
expression was not modified by GH treatment 
(data not shown). Taken together, we 
demonstrated that GH and IGF-1 modulate 
distinct target genes implicated in the 
regulation of ionic transport in the CCD cells, 
a finding suggesting that both hormones could 
cooperate to control sodium balance.   
 
Discussion  
 
Even though the antinatriuretic effects of GH 
have been proposed long time ago (3), the 
mechanisms by which GH and/or IGF-1 
regulate sodium and water balance remain 
poorly understood. In the present study, several 
lines of evidence indicate direct antinatriuretic 
effects of GH in the late distal nephron. We 
demonstrate that acromegaly leads to enhanced 
amiloride-sensitive sodium transport in the 
CCD associated with GH-induced 
transcriptional activation and proteolytic 
maturation of ENaC.  
Renal metabolic studies in GC rats permitted 
to exclude a major contribution of Henle’s 
loop in sodium retaining effects of GH excess. 
Instead the increase in amiloride-stimulated 
natriuresis and the decrease in furosemide-
induced natriuresis together with the specific 
increase in Na+/K+-ATP-ase activity in CCD 
clearly revealed the pivotal role of the distal 
nephron as the major site of GH/IGF-1 induced 
sodium retention in acromegaly. Of interest, 
six weeks after tumor removal in GC rats with 
normal circulating GH concentrations, the 
natriuretic responses to furosemide and 
amiloride challenge returned to the normal 
ranges (data not shown), indicating that 
chronic GH and/or IGF-1 exposure are indeed 
responsible for altered Na+ excretion. 
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However, these functional renal investigations 
do not permit to precise the relative 
contribution of GH and IGF-1 to the increased 
sodium transport prevailing in the CCD. 
Considering the distinct half-lives of GH (18 
min) and IGF-1 (8-9 h) (27, 28), the massive 
polyuria and dramatic tissue swelling 
regression generally observed few hours after 
pituitary tumor removal in acromegalic 
patients support a direct and rapid control of 
renal sodium reabsorption by GH. Since GH 
concentrations in GC rats are about two orders 
of magnitude higher than those measured in 
acromegalic patients, one has to be caution 
when translating these observations to human 
pathology. 
The molecular mechanisms by which GH 
exerts its antinatriuretic effects are not entirely 
clear. The major effect of amiloride on sodium 
excretion demonstrated in GC rats points out to 
a prominent role played by ENaC as the key 
mediator of GH action. Here, we show that 
chronic GH excess leads to major 
modifications in the proteolytic maturation of 
both α and γ subunits of ENaC in GC rat 
kidneys. Indeed, proteolytic cleavage of α and 
γ ENaC subunits by furin, a serine protease, is 
associated with increased channel activity (29, 
30). Recent studies suggested, that a second 
cleavage event within the γ ENaC subunit, by 
prostasin (31) or by neutrophil elastase (32), 
releasing an inhibitory peptide domain, was 
required to fully activate the channel (33). 
Along this line, the intermediate 80-kDa 
γ ENaC band observed in GC rats could 
represent an increased pool of   furin-
cleaved γ subunit. Finally, ENaC processing in 
the kidney is regulated by distinct 
physiological or pathological stimuli including 
hyperaldosteronism due to either sodium 
restriction or aldosterone administration (34, 
35). However, increased sodium reabsorption 
in the CCD accompanied by ENaC proteolytic 
maturation despite low plasma aldosterone 
concentrations in acromegalic rats provide 
additional evidence that GH/IGF-1 directly 
control ENaC activity, irrespective of the 
mineralocorticoid status. 
To gain more insight into the molecular events 
underlying GH-induced regulation of sodium 
reabsorption in the distal nephron, we 
employed the renal KC3AC1 cell line. To the 
best of our knowledge, our study is the first 
report demonstrating functional GHR 
expression in CCD-derived cells, the site of the 
aldosterone-sensitive sodium transport (36). In 
addition, since KC3AC1 cells did express 
functional IGF-1R but not IGF-1, this cell 
based system also enabled us to directly assess 
the impact of IGF-1 actions on CCD cells, 
independently from those induced by GH. As 
expected, GH treatment of KC3AC1 cells 
resulted in activation of canonical 
JAK2/STAT5 and ERK1/2 signaling pathways 
(37) and in the induction of classical GH target 
genes such as SOCS2 and CIS (38, 39). One of 
the main findings is that GH also exerts direct 
stimulatory effects on transcriptional 
regulation of αENaC expression. This effect 
appears to be linked to JAK2/STAT5 
activation, as we have identified a STAT5 
response element in the promoter of SCNN1A 
gene conserved in mice, rats and humans. 
Since a cross-talk between cytokine receptor 
signaling pathways and steroid receptors has 
been already documented (40), a functional 
link between mineralocorticoid receptor (MR), 
the key transcriptional regulator in CDD cells, 
and STAT5 is very likely given the vicinity of 
their respective response elements on the 
SCNN1A promoter. Whether MR and STAT5 
physically interact and how they functionally 
cooperate to activate transcription remains to 
be addressed experimentally. 
Our study conclusively demonstrates that GH 
exposure not only stimulates transcription of 
αENaC but also affects ENaC subunits 
proteolytic maturation. Considering that ENaC 
activity depends on other complex regulatory 
mechanisms including post-transcriptional 
regulation by Nedd4-2-mediated 
ubiquitinylation that controls apical membrane 
abundance as well as alteration of the open 
probability (Po) of functional channels (34, 36, 
41), it remains to investigate whether the 
antinatriuretic effects of GH may also involve 
modification in the residency time and 
functional properties of the apical channels.  
From a physiological perspective, it is 
interesting to note that lactogens and GH 
signaling play essential role in the 
osmoregulation and in the salinity adaptation 
of teleost fishes (42, 43). Consistent with our 
finding, a recent study suggests that prolactin 
induces sodium transport via stimulation of 
ENaC and Na+/K+-pump activities in the 
amphibian skin (44). Lactogen/GH-dependent 
ENaC activation could represent an important 
phylogenetic axis in the control of the “milieu 
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intérieur” conserved throughout hundreds 
millions of years of evolution. 
Beside GH, IGF-1 also stimulates 
transepithelial sodium transport, in accordance 
with previous studies on other mammalian and 
amphibian cell lines (45-48). It has been 
proposed that, like insulin (49), IGF-1 controls 
sodium transport via increase in Sgk1 protein 
level and PI-3K-mediated Sgk1 
phosphorylation (48), leading to subsequent 
inactivation of the ubiquitin ligase Nedd4-2 
(41). Here, we provide first evidence that IGF-
1 also regulates Sgk1 transcription which, 
together with its well-known aldosterone 
dependent induction (50), represents an 
additional cross-talk bewteen aldosterone and 
IGF-1 signaling pathway. 
Based on our results, we propose a model of 
cooperative GH and IGF-1 action in CCD cells 
leading to an intricate control of transepithelial 
sodium reabsorption that is schematized in 
Figure 8. GH binding to GHR triggers 
activation of JAK2/STAT5 and MAP kinase 
pathways, leading to transcriptional activation 
of the classical and kidney-specific GH target 
genes including αENaC. ENaC activity is also 
modulated by post-transcriptional and post-
translational events including proteolytic 
maturation of α and γ  subunits. IGF-1, locally 
synthesized in the kidney or produced in the 
liver, binds to IGF-1R and regulates apical 
membrane abundance of ENaC via PI-3K-
dependent Sgk1 activation (47, 48).  
In summary, our findings reveal the critical 
role of GHR signaling in sodium transport of 
CCD cells. The demonstration of a direct GH 
action mediated by ENaC activation provides a 
novel mechanism which, in concert with IGF-
1, accounts for the regulation of sodium 
homeostasis. Given the importance of sodium 
balance in the pathogenesis of arterial 
hypertension, our study opens new therapeutic 
strategies to prevent or cure cardiovascular 
complications in acromegalic patients. 
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Figure Legends 
 
Figure 1:  Renal hypertrophy in GC rats is not accompanied by modification of tubular diameter. A) 
Morphologic features of wild type (WT) and GC rat kidney; the scale is in mm. B) Comparison of 
kidney weight (left panel) and kidney weight/body weight ratio (right panel) in WT and GC rats; body 
weight of WT rats was 207 ± 3.7 g and of GC rats was 434.7 ± 16.4 g. (mean ± SEM , n=10 ; ** 
P<0.01). C) Histological features of WT and GC rat kidneys (Magnification x10, bar = 100 µm) D) 
Representative microdissected CCD of WT and GC rats (Magnification x 2.5 , bar = 100 µm). 
 
Figure 2: The amiloride-sensitive distal nephron is the site of enhanced sodium transport in GC rats 
independently of aldosterone action 
A-B) Metabolic studies of renal Na+ and K+ handling in basal conditions, and 3 h after furosemide 
injection (40 mg/kg) (A) and 24 h after oral amiloride administration (150 mg/L of water) (B). Left 
panels represent basal and furosemide- (A) or amiloride- (B) induced natriuresis normalized by 
urinary creatinine in WT () and GC () rats; right panels show urinary Na+/K+ ratio in the same 
experiments. Data are expressed as mean ± SEM, n=10 (** P<0.01, *** P <0.001).    
C) Plasma aldosterone concentrations in WT and GC rats. Values are means ± SEM, from 8 control 
and 6 GC rats,  ** P< 0.01 
D) Na+/K+-ATP-ase activity in proximal convoluted tubule (PCT), cortical thick ascending limb of the 
Henle’s loop (cTAL) and CCD from WT and GC rats. Values (in pmol/mm/h) are means ± SEM from 
5 controls and 6 GC rats; *** P< 0.001.  
 
Figure 3: ENaC subunits expression and processing is altered in GC rats 
A (α subunit), B (β subunit), and C (γ subunit): Representative immunoblots of WT (the first three 
lanes) and GC rat (the last four lanes) kidneys. Twenty micrograms of protein from whole kidney 
homogenates were loaded onto each lane. Immunoblots were incubated with 1 :1000 dilutions of anti-
α, β and γENaC antibodies. Protein loadings were normalized by reblotting with anti-α-tubulin 
antibody. 
 
Figure 4: GHR and IGF-1R are expressed in KC3AC1 cells 
A) Relative GHR and IGF-1R expression along different segments of the mouse nephron was 
evaluated by quantitative real time PCR. PCT: proximal convoluted tubule; PST: proximal straight 
tubule; mTAL, cTAL: medullary, cortical thick ascending limb of the Henle’s loop; DCT: distal 
convoluted tubule; CNT: connecting segment; CCD: cortical collecting duct; OMCD: outer medulla 
collecting duct. Results (molecule/mm tubule length) are expressed as means ± SEM from 5 mice. 
Note that the scale for GHR expression in PCT and PST (white bars) is ten times higher than that for 
the other tubular segments (black bars). 
B) Morphologic features of subconfluent (left panel) and differentiated dome-forming (right panel) 
KC3AC1 cells on phase-contrast micrographs (magnification x 20).  
C) GHR and IGF-1R mRNA expression in undifferentiated and differentiated KC3AC1 cells were 
quantified by quantitative real time PCR analysis. A 2.5-fold increase in GHR transcript levels was 
observed in dome-forming cells as compared to undifferentiated cells whereas IGF-1R expression was 
only increased by 50%. Results are mean ± SEM of at least 9 independent determinations and 
represent fold induction above basal expression which was 0.091 ± 0.015  and 0.305 ± 0.046 amol 
/fmol of 18S for GHR and IGF-1R, respectively (*** p <0.001, ** p<0.01). 
D and E) Western blot analysis of GHR (D) and IGF-1Rα (E) expression in KC3AC1 cells. Thirty µg 
of proteins from KC3AC1 cell homogenates, wild-type (WT) and GHR KO kidney and liver were 
processed for immunoblotting with anti-GHR. Note the presence of a specific 115 kDa band for GHR 
in KC3AC1 cells. Ten or 50 µg of proteins extracted from KC3AC1 cells or whole kidney, 
respectively, were used for IGF-1R detection which revealed a 200 kDa and a 130 kDa specific band 
for IGF-1R. 
F and G) Immunocytochemical detection of GHR (F) and IGF-1R (G) in dome-forming cells (upper 
panels) and cells cultured on filters (lower panels).  
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Figure 5: GHR and IGF-1R signaling in KC3AC1 cells  
A and B) KC3AC1 cells were stimulated with 1000 ng/ml GH for 0 to 60 min (A) or increasing 
concentrations of GH for 15 min (B) or with 10 µg/ml pegvisomant (Peg) or 10 µM AG490 alone (-) 
or in the presence of 1000 ng/ml GH (+ GH). Lysates were prepared at indicated time and 1 mg 
proteins were immunoprecipitated (IP) with anti-STAT5 antibody followed by western blotting (WB) 
using anti-phospho-tyrosine antibody. Membranes were reblotted with anti-STAT5 antibody for 
loading control. 
C) KC3AC1 cells grown on Lab-Tek were incubated or not with 100 ng/ml GH for 15 min. 
Immunocytochemistry with an anti-phospho-STAT5 antibody revealed a specific nuclear staining in 
the GH-treated cells (see inset).  
D and E) For ERK1/2 pathway, cells were treated with 1000 ng/ml GH for 0-30 min and direct WB 
on 30 µg protein lysates was performed with anti-phospho-p44/42 antibody (D). Similar experiments 
were performed in the absence or presence of 1000 ng/ml GH alone or with 10 µg/ml Peg or 10 µM 
U0126 for 2 min (E). Protein loadings were normalized by reblotting with anti-p44/p42 antibody. 
F and G) KC3AC1 cells were stimulated with 10 nM IGF-1 for 0 to 30 min alone or in the presence 
of 10 µM U0126 or 10 µM Ly294002 (Ly) for 5 min. 30 µg protein lysates were submitted to direct WB 
using anti-phospho-p44/42 (F) or anti-phospho-AKT antibodies (G). Protein loadings were normalized 
with the corresponding antibodies.  
 
Figure 6: GH and IGF-1 stimulate ionic transport in KC3AC1 cells  
KC3AC1 cells seeded on collagen I-coated Transwell filters were starved for 24 h in minimum 
medium and treated or not (Basal) for 24 h with 100 ng/ml GH alone or with 10 µg/ml Peg (A-C). 
Similar experiments after 24 h starvation in minimum medium with insulin omission were performed 
with 10 nM IGF-1 treatments (D-F). Supernatants were recovered from the apical and basolateral 
compartments and Na+, Cl- and K+ concentrations were measured. Ionic gradients representing the 
differences between basolateral versus apical Na+ and Cl- concentrations or the differences between 
apical versus basolateral K+ concentrations were calculated. Results are mean ± SEM of independent 
determinations and represent fold induction above basal ionic gradient. (A = apical; B = basolateral * 
p<0.05, ** p<0.01, *** p <0.001). 
A-C) Basal Na+, Cl- and K+ concentration gradients in mmol/L/24 h were 4.40 ± 0.61, 3.60 ± 0.34 and 
1.22 ± 0.21, respectively; n = 10.  
D-F) Basal Na+, Cl- and K+ concentration gradients in mmol/L/24 h were 4.76 ± 0.43, 3.53 ± 0.33 and 
1.46 ± 0.17, respectively; n = 13.  
 
Figure 7: GH and IGF-1 increase the expression of specific target genes in KC3AC1 cells.  
A) Induction of SOCS2, CIS and αENaC mRNA expression in KC3AC1 cells by GH. Cells were 
incubated in minimal medium 3 h before exposure to GH (100 ng/ml) for 24 h. mRNA expression was 
measured by quantitative real time PCR. Results expressed as amol/fmol of 18S are mean ± SEM of 6 
independent determinations (* P <0.05, ** P<0.01, *** P<0.001). 
B) Specific binding to a STAT5 response element located in the αENAC promoter region. The 
sequence of the STAT5-RE oligonucleotide is underlined in bold. Nuclear extracts (5 µg proteins) 
from GH-treated (lane 1) and untreated KC3AC1 cells (lane 3) were analyzed for binding to a double-
stranded STAT5-RE oligonucleotide. After a 15-min incubation of proteins with 105 cpm of [32P]-
radiolabeled STAT5-RE, protein-DNA complexes were separated on a nondenaturing 4.5% 
polyacrylamide gel and detected by autoradiography. Specific complexes were identified by 
competition experiments in which 100 ng unlabeled STAT5-RE was added (lanes 2 and 4).  
C) KC3AC1 cells were starved for 24 h in minimum medium without insulin and exposed to 10 nM 
IGF-1 for various periods of time. Relative expression levels of Sgk1 and αENAC transcripts were 
determined by quantitative real time PCR analysis. Results are mean ± SEM of 6 independent 
determinations and represent fold induction above basal arbitrary set at 1 (* P <0.05, ** P <0.01). 
Basal expression of Sgk1 is 0.386 ± 0.014 amol/fmol 18S, and of αENaC 0.143 ± 0.004  amol/fmol of 
18S. 
 
Figure 8: Proposed model of cooperative GH and IGF-1 action in cortical collecting duct cells. 
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Name     Accession number   Amplicon         Sense primer  Antisense primer 
 
18S  X00686 66 bp  CCCTGCCCTTTGTACACACC CGATCCGAGGGCCTCACTA 
GHR  NM_010284 150 bp CCAAGTGTCGTTCCCCTGA TGGGTCCATTCATGAGCAATT   
IGF-1 NM_010512 150 bp CACCACAGCTGGACCAGAGAC ACACTCATCCACAATGCCTGTC 
IGF-1R  NM_010513 150 bp  CGGTGACTTCTGCTCAAATGC GAATGGCGGATCTTCACGTAG 
αENaC NM_011324  150 bp GGACTGGAAAATCGGCTTCC TAGAGCAGGCGAGGTGTCG  
Sgk1    AF205855 150 bp TCACTTCTCATTCCAGACCGC ATAGCCCAAGGCACTGGCTA 
SOCS2    NM_007706 119 bp GAGACTTTGCCACACCATTCTG TCACAGGGTACCCCAAAACG 
CIS    AK_170877 150 bp CTCCTACCTTCGGGAATCTGG ACGGGTGGTTTTGACTGACAG 
MR  M36074   153 bp   ATGGAAACCACACGGTGACCT AGCCTCATCTCCACACACCAAG 
 
 
Supplemental Table 1: Primer sequences of genes analyzed in RT-PCR and quantitative real-time 
PCR 
The abbreviations of the murine genes, their full name, their GENBANK or NCBI accession number 
and 5’ to 3’ nucleotide sequences of the sense and antisense primers are presented. 
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